Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for IMMUNE GLOBULIN (HUMAN)
- Safety and Efficacy Study of hAESCs Therapy for aGVHD
- Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matche
- Hyperpolarized 13C MRI for Cancer Immunotherapy
- A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia
- Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation
- Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children
- Optimal Conditioning Regimen for Autologous Transplantation of Relapsing Remitting Multiple Sclerosis
- Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
- Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates
- Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED) Associated Alopecia Areata
- Clinical Efficacy of Ulinastatin for Treatment of Sepsis With Systemic Inflammatory Response Syndrome
- Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies
- Preservation and Transfer of HBV Immunity After Allogeneic HSCT for SCD.
- AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS
- Stop Hep B @ Birth
- TReatment for ImmUne Mediated PathopHysiology
- A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients
- Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies
- A Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-up and No Ramp-up Dosing in Healthy Adult Participants
- Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer
- Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease
- Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)
- Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis
- Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19)
- Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation
- Matched Related and Unrelated Donor Stem Cell Transplantation for Severe Combined Immune Deficiency (SCID): Busulfan-based Conditioning With h-ATG, Radiation, and Sirolimus
- Tocilizumab Treatment in Patients With COVID-19
- Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
- Treg Modulation With CD28 and IL-6 Receptor Antagonists
- Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders
- Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant
- Combination of Thrombopoietin Mimetic and Immunosuppressive Therapy in Aplastic Anaemia
- Autologous Transplant To End NMO Spectrum Disorder
- Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
- Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation
- ATG-F VS ATG for the Prevention of GVHD
- Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant
- ATG/PTCy in Haplo-PBSCT Randomized Controlled,Multi-center
- Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Cardiac Safe Transplants for Systemic Sclerosis
- Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis B
- Proof-of-Concept: A Pilot, Randomized, Double-Blind Study of Oseltamivir Versus Placebo for Immune Thrombocytopenia
- Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation
- Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical Transmission
- Eltrombopag+hATG+CsA vs. hATG+CsA in Children With Severe AA
- IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3
- Peripheral Blood Allogenic Stem Cell Transplantation Using Non-anti Thymocyte Globulin Regimens in Severe Aplastic Anemia Patients
- Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation
- Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies
- Eltrombopag in Children With Idiopathic Aplastic Anemia
- Autologous Stem Cell Transplant for Crohn's Disease
- Panzyga in CIDP Administered at Different Infusion Rates
- Stem Cell Therapy for Patients With Multiple Sclerosis Failing Alternate Approved Therapy- A Randomized Study
- Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID)
- ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors
- The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes
- Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients
- Omental Islet Transplant
- Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients
- Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis.
- Autologous Hematopoietic Stem Cell Transplantation for Allogeneic Organ Transplant Tolerance
- The Research of Standard Diagnosis and Treatment for Severe HSP in Children
- Romidepsin Maintenance After Allogeneic Stem Cell Transplantation
- Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
- A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis
- CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma
- Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver Transplantation
- Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia
- ATG Could Improve the Outcome Of Hematopoietic Stem Cell Transplant in Patients With Highly Aggressive T Cell Tumors
- An Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocerebellar Ataxias
- Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept Study
- Efficacy and Safety of Two Anti-T-lymphocyte Immune Globulin (ATG-F) Induction Regimens in Anew Kidney Transplant Patients
- Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome
- Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease
- Trial of Adoptive Immunotherapy With TRACT to Prevent Rejection in Living Donor Kidney Transplant Recipients
- Hematopoietic Stem Cell Transplant for Sickle Cell Disease
- An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia
- Phase II/III Study of the Safety and Effectiveness of HRIG With Active Rabies Vaccine in Healthy Subjects
- IVIG Treatment for Asthmatic Patients With IgG Subclass Deficiency
- Role of Everolimus in Highly Sensitized Patients
- Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis
- Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
- Intravenous Gammaglobulin for Sickle Cell Pain Crises
- Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand
- Long-Term Study of IGIV, 10% in Alzheimer´s Disease
- Belatacept Early Steroid Withdrawal Trial
- CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies
- Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia
- A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients
- Multi-Drug Desensitization Protocol for Heart Transplant Candidates
- High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant
- Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease
- Evaluating the Effectiveness of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic Ganglionopathy
- Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants
- Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
- Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies
- Scleroderma Treatment With Autologous Transplant (STAT) Study
- Vaccine+HBIG Versus Vaccine+Placebo for Newborns of HBsAg+ Mothers
- Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency
- Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG
- Research Study of ATG and Rituximab in Renal Transplantation
- Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS)
- Alefacept in Patients With Relapsed/Refractory Aplastic Anemia
- Phase 2/3 Study of IGSC, 20% in PIDD
- Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
- Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia
- A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia
- Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia
- Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
- Prophylaxis of Hepatitis B Virus Recurrence After Liver Transplantation
- Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients
- Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant
- Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis
- Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
- Hematopoietic Stem Cell Transplant for Fanconi Anemia
- Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies
- Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells
- Rituximab in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
- Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation
- Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
- Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation
- Infusion of Expanded Cord Blood T Cells
- Umbilical Cord Blood Transplant for Congenital Pediatric Disorders
- Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment
- Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation
- Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC
- Efficacy and Safety of Intramuscular HBIG Grifols for the Prevention of Recurrence After Liver Transplantation
- Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.
- Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies
- Evaluation of Serum Levels and Pharmacokinetics of a New Hepatitis B Immune Globulin Following Liver Transplantation
- Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer
- Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin
- Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)
- Autologous Hematopoietic Stem Cell Transplantation for Early Onset Type 1 Diabetes
- Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer
- Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome
- Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to Treatment
- Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer
- Hematopoietic Stem Cell Transplant in Devic's Disease
- Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders
- Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
- Autologous Peripheral Blood Stem Cell Transplant for Neurologic Autoimmune Diseases
- Thymoglobulin: Presence and Affect in the Central Lymphatic Compartment
- Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT
- Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant
- Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
- IVIg Therapy for Patients With Idiopathic Cardiomyopathy and Endomyocardial Biopsy Proven High PVB19 Viral Load
- Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda
- Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma
- Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia
- Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer
- A Pilot Trial of Rituxan in Refractory Myasthenia Gravis
- Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
- Busulfan, Cyclophosphamide, and Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
- Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil
- T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer
- Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer
- Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients
- Rituximab for GVHD
- Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis
- Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia
- Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia
- Comparison of Intravenous and Subcutaneous Administration of IGIV, 10% in Primary Immunodeficiency (PID) Subjects
- Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders
- Study of Antithymocyte Globulin for Treatment of New-onset T1DM
- Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients
- MMF vs. AZA for Kidney Transplantation
- Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies
- Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant
- A Clinical Study of Intravenous Immunoglobulin
- Preventive IVIG Therapy for Congenital Heart Block
- Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
- Tetanus Immunization in Subjects With No Immunization History or With Tetanus Antibody Levels Below Protective Levels
- Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors
- Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes
- Mycophenolate Mofetil in Systemic Sclerosis
- Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma
- Donor Stem Cell Transplantation for Congenital Immunodeficiencies
- Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis
- Thymoglobulin (ATG) Dose Finding Study
- Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease
- Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease
- Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant
- A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP.
- Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer
- Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant
- Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT)
- Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer
- Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow Transplant
- Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection
- Oral Mifepristone and Buccal Misoprostol Administered Simultaneously for Abortion Through 63 Days Gestation
- Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia
- Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma
- Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma
- Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis
- Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in Firs
- Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
- Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
- Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer
- Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer
- Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia
- Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease
- Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease
- Hematopoietic Stem Cell Support in Vasculitis
- Stem Cell Therapy for Patients With Multiple Sclerosis Failing Alternate Approved Therapy- A Randomized Study
- Aerosol Cyclosporine for Prevention of Lung Rejection
- A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis
- Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients
- Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)
- IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency
- HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection
- Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration
- Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis
- Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients
- Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP
- Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis
- Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer
- Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy
- Alemtuzumab to Treat Severe Aplastic Anemia
- Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies
- T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
- Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura
- Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia)
- Stem Cell Transplantation for Patients With Hematologic Malignancies
- Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome
- Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus
- Trial of Pulse Steroid Therapy in Kawasaki Disease--Pediatric Heart Network
- Comparing Methotrexate Followed by Misoprostol to Misoprostol Alone for Early Abortion
- Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants
- Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors
- Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
- Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
- Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
- Evaluation and Treatment of Eye Complications of Vaccinia Vaccination
- Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Metastatic Breast Cancer
- Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission
- Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies
- Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates
- Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever
- Prevention of Recurrent Hepatitis B After Liver Transplantation
- Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
- Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS
- Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
- Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin
- Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer
- Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma
- Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus
- Stem Cell Mobilization Potential in Patients With Aplastic Anemia in Remission
- Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection
- Non-Ablative Allo HSCT For Hematologic Malignancies or SAA
- Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia
- Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy
- Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis
- Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis
- Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection
- Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal Diabetic Neuropathy
- Study of Human Botulism Immunoglobulin in Infants With Botulism
- Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy
- Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
- Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease
- Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
- Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer
- Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer
- The Effectiveness of Cow's Milk Immune Globulin in the Treatment of AIDS-Related Diarrhea
- Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)
- A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS
- A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure
- Comparing Therapies for the Treatment of Severe Aplastic Anemia
- Study of Immune Responses and Safety of Recombinant Human CD40 Ligand in Patients With X-Linked Hyper-IgM Syndrome
- Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia
- A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children
- A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
- Transfusion-Transmitted Cytomegalovirus Prevention in Neonates
- Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin
Clinical trials list
click for details